All sites C00-96,D32-33,D42-43,D45-47,D76 497 88.8 2.6 4.4 1.1 3.1
Mouth, pharynx C00-14 6 83.3 3.3 - - 13.3
  Lip C00 1 100.0 - - - -
  Tongue C02 1 100.0 - - - -
  Mouth, other C03-06 2 66.7 - - - 33.3
  Salivary glands C07-08 1 60.0 20.0 - - 20.0
  Pharynx C01,C09-14 1 100.0 - - - -
Digestive organs C15-26 94 81.1 2.5 10.6 1.9 3.8
  Oesophagus C15 4 88.9 - 5.6 5.6 -
  Stomach C16 11 94.6 - 3.6 - 1.8
  Small intestine C17 1 85.7 - 14.3 - -
  Colon C18 32 96.2 - 2.5 - 1.3
  Rectum, rectosigmoid C19-20 14 95.7 - - 1.4 2.9
  Anus C21 0 100.0 - - - -
  Liver C22 6 82.1 7.1 7.1 3.6 -
  Gallbladder, bile ducts C23-24 9 63.6 6.8 18.2 2.3 9.1
  Pancreas C25 16 41.8 8.9 35.4 5.1 8.9
  Other digestive organs C26 2 22.2 - 44.4 11.1 22.2
Respiratory organs C30-39 25 63.0 17.3 15.0 1.6 3.1
  Nose, sinuses C30-31 0 100.0 - - - -
  Larynx, epiglottis C32 0 100.0 - - - -
  Lung, trachea C33-34 24 62.0 18.2 15.7 1.7 2.5
  Mediastinum, pleura C38 0 100.0 - - - -
Bone C40-41 0 100.0 - - - -
Melanoma of the skin C43 18 100.0 - - - -
Skin, non-melanoma C44 27 100.0 - - - -
Mesothelioma C45 0 100.0 - - - -
Autonomic nervous system C47 - - - - - -
Soft tissues C48-49 3 100.0 - - - -
Breast C50 155 99.0 0.1 - 0.3 0.6
Female genital organs C51-58 59 94.6 2.4 0.7 0.7 1.7
  Cervix uteri C53 4 100.0 - - - -
  Corpus uteri C54 30 99.3 - - - 0.7
  Uterus, other C55,C58 0 100.0 - - - -
  Ovary C56 15 85.7 9.1 2.6 1.3 1.3
  Other female genital C51-52,C57 9 90.9 - - 2.3 6.8
Urinary organs C64-68 20 88.1 1.0 5.0 - 5.9
  Kidney C64 13 84.6 - 6.2 - 9.2
  Bladder and urinary tract2 C65-68 7 94.4 2.8 2.8 - -
Eye C69 0 100.0 - - - -
Brain, central nervous system C70-72,D32-33,D42-43 18 83.0 - 9.1 2.3 5.7
Thyroid gland C73 11 96.4 3.6 - - -
Other endocrine glands C74-75 0 100.0 - - - -
Illdefined or unknown C76,C80 16 55.7 7.6 24.1 3.8 8.9
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 44 77.3 5.9 2.7 3.6 10.5
  Hodgkin lymphoma C81 1 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 20 100.0 - - - -
  Malignant immunoproliferative diseases C88 0 100.0 - - - -
  Myeloma and other plasma cell tumors C90 6 51.6 3.2 12.9 12.9 19.4
  Leukaemia C91-95 10 64.7 13.7 2.0 2.0 17.6
  Myelodysplastic syndromes D46 2 18.2 27.3 9.1 9.1 36.4
  Myeloproliferaitive neoplasms D45,D47 4 55.6 11.1 - 11.1 22.2
Not included above
  Carcinoma in situ of the breast D05 10 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 50 100.0 - - - -
  Borderline tumour of the ovary D39 4 95.2 - - - 4.8
  Basal cell carcinoma of the skin 170 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.